Based on the patient case study provided, I will compose a scholarly analysis focusing on the pathophysiological aspects of Crohn’s disease and its complications, as observed in the presented case. This analysis will address key aspects of the patient’s condition, treatment, and associated complications.<\/p>\n
Crohn’s Disease: Pathophysiological Insights and Complications<\/p>\n
Crohn’s disease is a chronic inflammatory bowel disease characterised by transmural inflammation that can affect any part of the gastrointestinal tract. The case of C.D., a 32-year-old woman with a 14-year history of Crohn’s disease, illustrates several important pathophysiological aspects and complications associated with this condition and its treatment.<\/p>\n
Adrenal Insufficiency and Steroid Dependency<\/p>\n
One of the significant complications observed in this patient is adrenal insufficiency, which has developed as a result of chronic steroid use. The pathophysiological mechanism underlying this complication involves the suppression of the hypothalamic-pituitary-adrenal (HPA) axis due to prolonged exogenous glucocorticoid administration (Prete et al., 2020). Chronic exposure to high doses of steroids, such as prednisone, leads to negative feedback on the hypothalamus and pituitary gland, reducing the production of corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone (ACTH), respectively. This, in turn, results in atrophy of the adrenal glands and diminished endogenous cortisol production.<\/p>\n
The patient’s laboratory results confirm this condition, with an ACTH level of 2 pg\/mL, which is significantly below the normal range. This low ACTH level indicates suppression of the HPA axis and consequently, inadequate stimulation of the adrenal glands to produce cortisol.<\/p>\n
Bone Demineralisation and DEXA Scan Abnormalities<\/p>\n
The abnormal DEXA scan demonstrating significant bone demineralisation in this patient can be attributed to multiple factors. Primarily, the chronic use of glucocorticoids is a significant contributor to bone loss. Glucocorticoids impair bone formation by inhibiting osteoblast function and promoting osteoblast and osteocyte apoptosis (Compston, 2018). Additionally, they enhance bone resorption by increasing osteoclast activity and lifespan.<\/p>\n
Furthermore, Crohn’s disease itself can contribute to bone loss through various mechanisms. These include malabsorption of calcium and vitamin D due to intestinal inflammation and resection, chronic inflammation leading to increased cytokine production that promotes bone resorption, and reduced physical activity during disease flares (Szafors et al., 2020).<\/p>\n
Nutritional Deficiencies and Malabsorption<\/p>\n
The patient’s medication regimen includes intramuscular cyanocobalamin (vitamin B12) supplementation, indicating the presence of vitamin B12 deficiency. This deficiency is common in Crohn’s disease patients, particularly those with ileal involvement or resection, as the terminal ileum is the primary site of vitamin B12 absorption. The pathophysiology involves either direct inflammatory damage to the ileal mucosa or surgical removal of the absorption site, leading to impaired vitamin B12 uptake (Weisshof and Chermesh, 2015).<\/p>\n
Cushingoid Appearance and Metabolic Alterations<\/p>\n
The patient’s cushingoid facial appearance and truncal obesity with abdominal striae are likely consequences of chronic glucocorticoid therapy. These features result from the metabolic effects of excess glucocorticoids, including increased fat deposition in characteristic areas (face, trunk, and dorsocervical region) and protein catabolism leading to skin thinning and striae formation (Prete et al., 2020).<\/p>\n
The patient’s laboratory results also reveal metabolic alterations consistent with chronic glucocorticoid use, including hypokalemia (3.0 meq\/L) and hyperglycemia (fasting glucose 120 mg\/dL). These findings reflect the mineralocorticoid effects of prednisone and its impact on glucose metabolism, respectively.<\/p>\n
In conclusion, this case illustrates the complex interplay between Crohn’s disease pathophysiology and the side effects of long-term glucocorticoid therapy. It underscores the importance of careful monitoring and management of patients with chronic inflammatory bowel diseases to prevent and address complications associated with both the disease and its treatment.<\/p>\n
References<\/p>\n
Compston, J., 2018. Glucocorticoid-induced osteoporosis: an update. Endocrine, 61(1), pp.7-16.<\/p>\n
Prete, A., Yan, Q., Al-Tarrah, K., Akturk, H.K., Prokop, L.J., Alahdab, F., Foster, M.A., Lord, J.M., Karavitaki, N., Wass, J.A. and Murad, M.H., 2020. The cortisol stress response induced by surgery: A systematic review and meta-analysis. Clinical Endocrinology, 93(6), pp.728-743.<\/p>\n
Szafors, P., Che, H., Barnetche, T., Morel, J., Gaujoux-Viala, C., Combe, B. and Lukas, C., 2020. Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis. Osteoporosis International, 31(8), pp.1479-1490.<\/p>\n
Weisshof, R. and Chermesh, I., 2015. Micronutrient deficiencies in inflammatory bowel disease. Current Opinion in Clinical Nutrition & Metabolic Care, 18(6), pp.576-581.<\/p>\n
==============================<\/p>\n
PATIENT CASE
\nHPI
\nC.D. is a 32 yo woman with a 14-year Hx of Crohn disease who presents with a three-day Hx of diarrhea and steady abdominal pain. She has been referred by her PCP to the GI clinic.
\nThe clinical course of her disease has included obstruction due to small intestine stricture and chronic steroid dependency with disease relapse when attempting to taper steroids.
\nEndocrine tests reveal that she has developed adrenal insufficiency as a result of steroid use and a DEXA scan has demonstrated significant demineralization of bone.
\nPatient Case Question 1. What is the pathophysiologic mechanism for adrenal insufficiency in this patient?
\nPatient Case Question 2. What is a potential cause of the abnormal DEXA scan in this patient?
\nPSH
\n\u2022 Portion of small bowel resected 5 years ago (obstruction from scarring and stricture)
\n\u2022 Ovarian cyst drained, age 18
\n\u2022 Appendectomy, age 13
\nPMH
\n\u2022 Crohn disease diagnosed 14 years ago (weight loss, severe diarrhea with multiple bowel movements, abdominal pain, dehydration)
\n\u2022 Major depression
\nCASE STUDY
\nCROHN DISEASE 21
\nFor the Disease Summary for this case study,<\/p>\n
FH
\nNo family Hx of IBD
\nSH
\n\u2022 Has been married for 11 years and has two daughters who are healthy
\n\u2022 Works as a nurse with a local home healthcare agency
\n\u2022 Non-smoker and non-drinker
\nROS
\n\u2022 Up to 10 loose to semi-solid stools\/day, non-bloody
\n\u2022 Denies chills and canker sores
\n\u2022 Stable weight with good appetite
\n\u2022 Denies joint pain, skin lesions, blurred vision, and eye pain
\n\u2022 Some mild fatigue
\nMeds
\n\u2022 Prednisone, 40 mg po QD
\n\u2022 Trazodone, 100 mg po BID
\n\u2022 Cyanocobalamin, 250 \u00b5g IM Q month
\nPatient Case Question 3. For which condition has trazodone been prescribed for this
\npatient?
\nPatient Case Question 4. Why is this patient taking cyanocobalamin IM?
\nPatient Case Question 5. Based on your analysis of this patient\u2019s medication profile
\nalone, what can you deduce about the degree of severity (mild to moderate or severe) of
\nCrohn disease in this patient?
\nAll
\n\u2022 Codeine \u2192 nausea and vomiting
\n\u2022 IV dye \u2192 acute renal failure
\nPE and Lab Tests
\nGen
\n\u2022 Overweight white female, somewhat anxious, moderate acute distress from chronic pain
\n\u2022 Cushingoid facial appearance
\nPatient Case Question 6. What is likely the cause of this patient\u2019s cushingoid facial appearance?
\nPatient Case Question 7. Briefly describe a cushingoid facial appearance.
\nVS
\nBP 165\/95, P 69, RR 15, afebrile, Ht 61 in, Wt 154 lbs
\nPatient Case Question 8. What is the most likely cause of the abnormal vital sign of most concern above?
\nSkin
\n\u2022 Warm and dry with flakiness
\n\u2022 Poor turgor
\nPatient Case Question 9. What do the examination findings in the skin suggest?
\nHEENT
\n\u2022 PERRLA
\n\u2022 EOMI
\n\u2022 Mild arteriolar narrowing on funduscopic exam without hemorrhages, exudates, or
\npapilledema
\n\u2022 Sclera without icterus
\n\u2022 TMs intact and clear throughout with no drainage
\n\u2022 Dry mucous membranes
\nPatient Case Question 10. What does the phrase \u201csclera without icterus\u201d suggest?
\nPatient Case Question 11. Identify the two abnormal HEENT findings above and provide a pathophysiologic explanation for each of them.
\nNeck
\n\u2022 Supple
\n\u2022 No masses, JVD, lymphadenopathy, or thyromegaly
\nLungs
\nCTA, no crackles or rales noted
\nHeart
\nRRR with no murmurs, rubs, or gallops
\nAbdomen
\n\u2022 Truncal obesity with abdominal striae
\n\u2022 Soft abdomen, not distended, and without bruits
\n\u2022 Guarding with pressure to right lower quadrant
\n\u2022 BS hyperactive<\/p>\n
CASE STUDY 21 \u25a0 CROHN DISEASE 101
\nPatient Case Question 12. What is a likely cause of \u201ctruncal obesity with striae\u201d?
\nPatient Case Question 13. What are striae?
\nPatient Case Question 14. What is meant by guarding?
\nRectal
\n\u2022 No perianal lesions or internal masses
\n\u2022 Stool is heme-negative
\nMS\/Ext
\n\u2022 No clubbing, cyanosis, or edema
\n\u2022 Appropriate strength and ROM
\n\u2022 Pulses 2\u0001 throughout
\n\u2022 No femoral bruits
\nNeuro
\n\u2022 A & O 3
\n\u2022 No gross motor or sensory deficits noted
\n\u2022 CNs II\u2013XII intact
\n\u2022 DTRs 2\u0001
\nLaboratory Blood Test Results
\nSee Patient Case Table 21.1
\nPatient Case Table 21.1 Laboratory Blood Test Results
\nSodium 141 meq\/L Aspartate aminotransferase 22 IU\/L
\nPotassium 3.0 meq\/L Alanine aminotransferase 54 IU\/L
\nChloride 106 meq\/L Total bilirubin 0.8 mg\/dL
\nBicarbonate 23 meq\/L Total protein 3.9 g\/dL
\nBlood urea nitrogen 19 mg\/dL Albumin 2.4 g\/dL
\nCreatinine 1.0 mg\/dL Calcium 8.7 mg\/dL
\nGlucose, fasting 120 mg\/dL Magnesium 2.9 mg\/dL
\nHemoglobin 13.8 g\/dL Phosphorus 3.3 mg\/dL
\nHematocrit 39% Adrenocorticotropic hormone 2 pg\/mL
\nPlatelets 180,000\/mm3 Erythrocyte sedimentation rate 24 mm\/hr
\nWhite blood cells 11,700\/mm3 C-reactive protein 1.6 mg\/dL
\nPatient Case Question 15. Identify the four abnormally elevated laboratory findings above and provide a brief and reasonable pathophysiologic explanation for each of them.
\nPatient Case Question 16. Identify the four abnormally low laboratory findings above and provide a brief and reasonable pathophysiologic explanation for each of them.<\/p>\n","protected":false},"excerpt":{"rendered":"
Based on the patient case study provided, I will compose a scholarly analysis focusing on the pathophysiological aspects of Crohn’s disease and its complications, as observed in the…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1157,798,774,790,627,1324,782,625,780],"tags":[1322,1323],"class_list":["post-4927","post","type-post","status-publish","format-standard","hentry","category-gastrointestinal-disorders-assignment-help","category-advanced-pathophysiology","category-assignment-pathophysiology-case-study-homework-help","category-case-study-answers-examples-for-nursing-healthcare-and-medicine-papers","category-how-to-write-a-case-study-examples-assignments","category-nursing-case-study-writing-assignment-help","category-nursing-pathophysiology-case-study-assignment","category-pathophysiology","category-pathophysiology-case-study-answers-examples","tag-c-d-is-a-32-yo-woman-with-a-14-year-hx-of-crohn-disease","tag-crohns-disease-pathophysiological-insights-and-complications"],"_links":{"self":[{"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts\/4927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/comments?post=4927"}],"version-history":[{"count":1,"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts\/4927\/revisions"}],"predecessor-version":[{"id":4928,"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/posts\/4927\/revisions\/4928"}],"wp:attachment":[{"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/media?parent=4927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/categories?post=4927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.homeworkacetutors.com\/nursing\/wp-json\/wp\/v2\/tags?post=4927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}